$70 Million Verdict Against J&J in Risperdal Trial

Largest Verdict Thus Far Against Jansen for $70 Million in Risperdal Trial According to Reuters, Janssen Pharmaceuticals, a unit of Johnson & Johnson, was hit with a $70 million verdict in a Risperdal trial last week, marking the largest verdict against Janssen thus far in this ongoing litigation. The award was handed down in the case of a 15 … [Read more...]

Testosterone Therapy Lawsuit Filed by South Carolina Couple

South Carolina Couple Files Lawsuit Against Pharmaceutical Companies Manufacturing Testosterone Therapy The latest of thousands of personal injury lawsuits filed against pharmaceutical companies due to testosterone therapy side effects comes from a South Carolina couple, who have both physically and emotionally suffered after one partner was … [Read more...]

FDA Finds Safety Problems With Eliquis

FDA Reviews Eliquis Data and Finds Safety Problems As More Lawsuits are Filed For the last few years, BristolMyers Squibb and Pfizer have pushed their joint anticoagulant, Eliquis, as safer than many other anticoagulants out on the market, including Pradaxa, Coumadin/warfarin, and Xarelto – all of which face personal injury and wrongful death … [Read more...]

SC Couple Keeps $11.6 Million in Topamax Birth Defect Damages Case

$11.6 Million Award for Topamax Birth Defect Damages Will Not Be Overturned A state Superior Court ruled in Pennsylvania that a South Carolina couple will be able to keep the damages awarded by the jury for birth defects caused by Topamax. Topamax, a drug used to treat epilepsy, has been tied to birth defects in children born to women who took … [Read more...]

Research Misconduct Can Lead to Defective Drugs or Devices

FDA, Medical Journals Rarely Report Violations in Clinical Trials, Which Can Lead to Defective Drugs or Devices A new study found that US health regulators often find serious problems in how clinical trials are conducted as research facilities, but their final, published reports almost never mention these issues. This can lead not only to … [Read more...]

Latest Dangerous Drugs Recalled: Prescription Painkillers

Mylan Voluntarily Recalls Two Dangerous Drugs On December 20th, Mylan voluntarily recalled two of their painkillers – hydrocodone bitartrate, and acetaminophen – up to 10 mg for hydrocodone, and 500 mg for acetaminphen. These two dangerous drugs were recalled by the manufacturer because it was discovered that the potency of the dosage may exceed … [Read more...]

Generic Wellbutrin pulled from the shelves

FDA announced certain generic Wellbutrin to be pulled off of the shelves. The 300 mg generic version of Wellbutrin XL made by Impax Laboratories and marketed by Teva Pharmaceuticals is being recalled.  Unusually, the recall is not because the medication has side effects, but rather because the medication doesn't work at all. This problem was not … [Read more...]

Video Games Can Help Promote Lifestyle Changes, Prevent Use of Dangerous Drugs like Actos

Recent studies into the therapeutic use of video games show that games can be used to promote a more active lifestyle, teach about self-care, empower patients to be more active in their treatment, and even build connections in the brain. These benefits can help patients, in the long-term, stay away from dangerous drugs like Actos and Avandia. The … [Read more...]

Actos Litigation Will Use New Predictive Coding to Sort Documents

The multidistrict litigation (MDL) against Takeda Pharmaceuticals and their Type 2 diabetes drug, Actos, is taking an interesting step forward with some technological help. The MDL was originally formed to help consolidate several similar cases against Takeda Pharmaceuticals, which allege that their drug Actos led to bladder cancer. Several … [Read more...]

Plaintiff Blames Actos for Husband’s Death

In October 2011, Thomas Harber died because he developed bladder cancer. His wife,Nancy, is now filing a lawsuit against Takeda Pharmaceuticals for producing andmarketing Actos, which she alleges caused her husband’s cancer. The lawsuit was filed August 10th, and moved into the multidistrict litigation against Actos in the US District Court in … [Read more...]

BestLawyers.comAVBetter Business Bureau